Search results
A tiny biotech's experimental treatment for a silent disease that strikes millions just cleared a...
Business Insider via Yahoo Finance· 1 year agoMadrigal Pharmaceuticals is hoping to succeed where others have failed in treating NASH, a serious...
Akero Therapeutics Wows Investors With Unexpected Win For Hepatitis Treatment
Investor's Business Daily· 2 years agoAkero Therapeutics wowed investors Tuesday with midstage test results for a hepatitis treatment, and...
Unleashing the Power of AI: HistoIndex Redefines NASH Clinical Trials with Stain-Free Tissue Imaging...
Exec Edge via Yahoo Finance· 12 months agoBy Daniella Parra HistoIndex will present advancements in AI-powered stain-free tissue imaging for...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript May 7, 2024 Madrigal...